Normal view MARC view ISBD view

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.

Miller, Jennifer E

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. [electronic resource] - BMJ open Dec 2017 - e017917 p. digital

Publication Type: Journal Article

ISSN: 2044-6055

Standard No.: 10.1136/bmjopen-2017-017917 doi

Subjects--Topical Terms:
Clinical Trials as Topic--ethics
Cross-Sectional Studies
Drug Approval--legislation & jurisprudence
Drug Industry--ethics
Humans
Research Report--standards
United States
United States Food and Drug Administration

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)